Quarterly report pursuant to Section 13 or 15(d)

Reconciliation of IFRS Disclosure to US GAAP Disclosure (Details) - Schedule of shareholders' equity

v3.21.2
Reconciliation of IFRS Disclosure to US GAAP Disclosure (Details) - Schedule of shareholders' equity
12 Months Ended
Nov. 30, 2018
USD ($)
Schedule of shareholders' equity [Abstract]  
Total shareholders’ equity in accordance with IFRS $ 33,936,971
Components of share capital in accordance with IFRS  
Share capital 81,495,274
Share option reserve 13,377,325
Share warrant reserve 4,783,244
Total components of share capital in accordance with IFRS 99,655,843
Adjustment for:  
Share-based compensation (325,265)
Share capital in accordance with US GAAP 99,330,578
Shares to be issued in accordance with IFRS and US GAAP 2,522,106
Deficit in accordance with IFRS (68,240,978)
Adjustment for:  
Capital raising fee adjustment 1,018,085
Share-based compensation 325,265
Deficit in accordance with US GAAP (66,897,628)
Shareholders equity in accordance with US GAAP $ 34,955,056